Search
Now showing items 1-2 of 2
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
(
Elsevier
, 2021 , Article)
ObjectivesCytokine release syndrome with elevated interleukin-6 (IL-6) levels is associated with multiorgan damage and death in severe coronavirus disease 2019 (COVID-19). Our objective was to perform a living systematic ...
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
(
Elsevier
, 2021 , Article)
ObjectivesCytokine release syndrome with elevated interleukin-6 (IL-6) levels is associated with multiorgan damage and death in severe coronavirus disease 2019 (COVID-19). Our objective was to update the data in a living ...